跳至主要内容
临床试验/EUCTR2020-002274-28-ES
EUCTR2020-002274-28-ES进行中(未招募)1 期

sefulness of vitamin D on morbidity and mortality of SARS-COV-2 virus infection (Covid-19) at the Central University Hospital of Asturias - Vitamin D and COVID-19

Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA)0 个研究点目标入组 60 人开始时间: 2020年5月21日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients treated in the ER or admitted to the HUCA Hospitalization unit.
  • Diagnosis of COVID19 demonstrated by positive PCR for SARS COV2 prior to randomization.
  • Age> = 18 years.
  • That they have accepted to participate in the study through informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • When discharge or a fatal outcome is expected within the next 48 hours.
  • Obvious cognitive impairment (inability to communicate).
  • PCR for SARS-COV 2 negative despite radiological, analytical and clinical findings compatible with this type of infection.
  • Allergy to vitamin D.
  • Patients who are receiving, or have received in the past 3 months, any form of vitamin D
  • Pregnant women

研究者

发起方
Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA)

相似试验